Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
Options
BORIS DOI
Publisher DOI
PubMed ID
22057700
Description
Estimates of drug resistance incidence to modern first-line combination antiretroviral therapies against human immunodeficiency virus (HIV) type 1 are complicated by limited availability of genotypic drug resistance tests (GRTs) and uncertain timing of resistance emergence.
Date of Publication
2012
Publication Type
Article
Language(s)
en
Contributor(s)
von Wyl, Viktor | |
Yerly, Sabine | |
Böni, Jürg | |
Shah, Cyril | |
Cellerai, Cristina | |
Klimkait, Thomas | |
Battegay, Manuel | |
Bernasconi, Enos | |
Cavassini, Matthias | |
Hirschel, Bernard | |
Vernazza, Pietro L | |
Ledergerber, Bruno | |
Günthard, Huldrych F | |
Swiss HIV Cohort, Study |
Additional Credits
Series
Clinical infectious diseases
Publisher
Oxford University Press
ISSN
1058-4838
Access(Rights)
open.access